Table 1.

Patients With Disparity for an HLA-DRB1 Allele

UPN No. of CD4 Cells/kg (×10−4) No. of CD8 Cells/kg (×10−6) Graft Failure GVHD Grade Survival (d) Cause of Death
GivenIntended
8399  BL  13.0  NA  No  IV  118 GVHD  
8343  BL  9.1  NA  No  III  39 Bacterial infection  
8358  0.069  5.6  5.0  No III  68  Bacterial infection  
8634  BL  5.0  5.0  No  III  166  CMV infection; chronic GVHD  
8650  0.35  4.6  5.0  NE  NE  Cardiomyopathy  
9303  3.7  4.3  5.0  No  III 57  CMV infection  
8441  BL  3.9  5.0  No III  465  P carinii infection; chronic GVHD  
9363  0.24  3.1  5.0  No  III  499 Recurrent malignancy  
8670  0.49  2.8  2.5  No II  >988  
9202  2.0  2.7  2.5  Yes  NE >956  
8286  BL  2.6  5.0  Yes  NE 173  Fungal infection  
8532  20  1.4  1.25  No I  >1,133  
8940  0.58  1.3  1.25  Yes  NE 26  Bacterial infection; hemorrhage  
8371 0.046  1.1  1.25  Yes  NE  508  Recurrent malignancy 
UPN No. of CD4 Cells/kg (×10−4) No. of CD8 Cells/kg (×10−6) Graft Failure GVHD Grade Survival (d) Cause of Death
GivenIntended
8399  BL  13.0  NA  No  IV  118 GVHD  
8343  BL  9.1  NA  No  III  39 Bacterial infection  
8358  0.069  5.6  5.0  No III  68  Bacterial infection  
8634  BL  5.0  5.0  No  III  166  CMV infection; chronic GVHD  
8650  0.35  4.6  5.0  NE  NE  Cardiomyopathy  
9303  3.7  4.3  5.0  No  III 57  CMV infection  
8441  BL  3.9  5.0  No III  465  P carinii infection; chronic GVHD  
9363  0.24  3.1  5.0  No  III  499 Recurrent malignancy  
8670  0.49  2.8  2.5  No II  >988  
9202  2.0  2.7  2.5  Yes  NE >956  
8286  BL  2.6  5.0  Yes  NE 173  Fungal infection  
8532  20  1.4  1.25  No I  >1,133  
8940  0.58  1.3  1.25  Yes  NE 26  Bacterial infection; hemorrhage  
8371 0.046  1.1  1.25  Yes  NE  508  Recurrent malignancy 

Patients are listed according to the number of CD8 cells in the graft.

Abbreviations: UPN, unique patient number; BL, below limits of detection; NA, not applicable because CD8 cells were not removed from the marrow for these patients; NE, not evaluable for graft failure because of early death, or not evaluable for acute GVHD because donor cells did not engraft.

or Create an Account

Close Modal
Close Modal